Anavex Life Sciences Corp (AVXL)

[circa1762]

On to the next trial, good deal. In the meantime, here's a look at the sort of thing that could happen if the next trial matches the exploratory efficacy shown in the current trial:

http://www.delawareonline.com/story/money/2015/11/17/how-az-drug-got-fast-approval/75945978/

Obviously AZ is helped by its massive resources, but the point is, the FDA is very much looking to expedite drugs that show good efficacy for indications without effective treatments. Anavex may not need a huge, expensive, long-lasting trial to gain approval for 2-73.